Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.
Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, Trang L.
Egsmose C, et al. Among authors: lund b.
J Rheumatol. 1995 Dec;22(12):2208-13.
J Rheumatol. 1995.
PMID: 8835550
Clinical Trial.
[The results after 2 years clearly favored early treatment (Borg G, Allander E, Lund B, et al: J Rheumatol 1988; 15:1747-54)]. RESULTS: After a total observation period of 5 years in 75 representative patients, continued improvement in the E group was demonstrated, …
[The results after 2 years clearly favored early treatment (Borg G, Allander E, Lund B, et al: J Rheumatol 1988; 15:1747-54)]. …